In out-of-hospital cardiac arrest patients, Stammet et al. [19] demonstrated in 686 patients randomized to targeted therapeutic hypothermia at 33 or 36 °C that serial NSE levels were not affected by hypothermia and were higher at all measurements within 72 h in patients with unfavorable outcomes at 6 months. The gene discussed is ENO2; the disease is cardiac arrest.